{"title":"Random Forest Modeling to Predict Small Molecule Accumulation in Gram-Negative Bacteria","authors":"Blake R. Levy, Paul J. Hergenrother","doi":"10.1021/acsinfecdis.6c00421","DOIUrl":null,"url":null,"abstract":"<p>Despite extensive efforts over the past ∼60 years\r\nto discover\r\nnew classes of Gram-negative-active antibiotics, the development pipeline\r\nremains relatively dry. These failures can be largely ascribed to\r\nthe complexity of the Gram-negative membranes and an inadequate understanding\r\nof physicochemical properties associated with compound permeation,\r\nefflux evasion, and overall accumulation in Gram-negative pathogens.\r\nRecent work using unbiased accumulation assays and advanced chemical\r\ndescriptors has utilized machine learning algorithms, particularly\r\nrandom forest modeling, to correlate physicochemical properties of\r\nsmall molecules with accumulation. The ability of a random forest\r\nclassifier to effectively process large data sets while still providing\r\nhuman-interpretable insight makes this model a valuable tool in accumulation\r\ndata analysis. Here, we describe in detail a workflow reliant on random\r\nforest modeling to probe physicochemical trends linked to small molecule\r\npermeation and/or efflux liabilities in Gram-negative pathogens. Applications\r\nusing random forest modeling have led to guidelines for small molecule\r\naccumulation in <em>E. coli</em> and <em>P. aeruginosa</em> that have resulted in multiple new\r\nGram-negative-active antibiotics. Random forest modeling possesses\r\nseveral distinct advantages over other machine learning models for\r\nthe purposes of identifying physicochemical trends in accumulation,\r\nand as such, provides valuable hypothesis-generating information for\r\nthe study of small molecule accumulation in Gram-negative bacteria.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 8","pages":"2558–2571"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00421","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Despite extensive efforts over the past ∼60 years
to discover
new classes of Gram-negative-active antibiotics, the development pipeline
remains relatively dry. These failures can be largely ascribed to
the complexity of the Gram-negative membranes and an inadequate understanding
of physicochemical properties associated with compound permeation,
efflux evasion, and overall accumulation in Gram-negative pathogens.
Recent work using unbiased accumulation assays and advanced chemical
descriptors has utilized machine learning algorithms, particularly
random forest modeling, to correlate physicochemical properties of
small molecules with accumulation. The ability of a random forest
classifier to effectively process large data sets while still providing
human-interpretable insight makes this model a valuable tool in accumulation
data analysis. Here, we describe in detail a workflow reliant on random
forest modeling to probe physicochemical trends linked to small molecule
permeation and/or efflux liabilities in Gram-negative pathogens. Applications
using random forest modeling have led to guidelines for small molecule
accumulation in E. coli and P. aeruginosa that have resulted in multiple new
Gram-negative-active antibiotics. Random forest modeling possesses
several distinct advantages over other machine learning models for
the purposes of identifying physicochemical trends in accumulation,
and as such, provides valuable hypothesis-generating information for
the study of small molecule accumulation in Gram-negative bacteria.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.